Steris (STE) Receivables - Other (2019 - 2020)

Steris (STE) posted quarterly Receivables - Other of $9.0 million for Q4 2020, up 4.93% quarter-over-quarter from $8.5 million in Q3 2020.

Steris (STE) Receivables - Other (2019 - 2020) Analysis & Trends

Steris' Receivables - Other history runs 2 years deep, the most recent figure standing at $9.0 million for Q4 2020.

In Q4 2020, Receivables - Other changed N/A year-over-year to $9.0 million; the TTM figure through Dec 2020 stood at $9.0 million (changed N/A YoY), while the FY2020 annual figure was $8.1 million, down 4.97% from the prior year.
Receivables - Other for Q4 2020 stood at $9.0 million, up from $8.5 million in the prior quarter.
The five-year high for Receivables - Other was $9.0 million in Q4 2020, with the low at $8.1 million in Q1 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Zimmer Biomet Holdings	19.04 Bn	18.63 Bn	1.54 Bn

Download Data